Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...

GLP-1 drugs pose an existential threat to CPAP-makers. ResMed is currently experiencing temporary tailwinds before potential long-term headwinds. ResMed (NYSE: RMD) finds itself in an investment limbo ...

Alphabet subsidiary Verily is teaming up with well-known sleep company ResMed to form a new venture that will focus on developing sleep apnea treatments and connected health products. The latest ...

ResMed is a leader in CPAP machines and other medical devices that help millions breathe better.

Jan 24 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for second-quarter revenue and profit on Wednesday, powered by strong demand for its respiratory devices used to treat sleep ...

(Reuters) - Medical equipment maker ResMed reported fourth-quarter revenue in line with estimates on Thursday, on steady demand for its sleep apnea treatment devices. The company's quarterly revenue ...

Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...

Some investors in ResMed, which makes machines for people with sleep apnea, think that effective new weight-loss drugs could shrink its addressable market. On ResMed's latest earnings call, CEO Mick ...

ResMed’s recurring revenue model leverages device sales, consumables, and SaaS, with growth driven by rising diagnosis and ...

Few observers think of CPAP machines as common fare where the med-tech patent wars are concerned, but Resmed Corp. recently came away with a win in litigation that resulted in the nullification of the ...